The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Meropenem (Meronem (1 gm)) is a carbapenem ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians, particularly healthcare providers, to one batch of counterfeit Meronem 1g Injection being purchased in ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerians, particularly healthcare providers, against a batch of counterfeit Meronem 1g injection being sold in the ...

The company has received a notice of termination from AstraZeneca UK conveying its decision for termination of distribution arrangements for Meronem in India AstraZeneca Pharma India will stop selling ...

The National Agency for Food and Drugs Administration and Control (NAFDAC) has called on consumers and healthcare professionals who have fallen victim to the counterfeit Meronem 1g injection currently ...

AstraZeneca Pharma stock plunged almost 11 percent today as it will stop selling anti- bacterial drug Meronem in India following a global deal by its UK parent to sell its small molecule antibiotics ...

The Delhi High Court has held that AstraZeneca was not entitled to an interlocutory injunction on the basis of its registration for and goodwill in Register for free to receive our newsletter, view ...

New Delhi: AstraZeneca Pharma India has got an extension from its parent firm AstraZeneca UK to sell anti-bacterial drug Meronem in India for the next six months. "AstraZeneca Pharma India Ltd has ...

AstraZeneca Pharma has received a letter from AstraZeneca UK Ltd to further extend the date of withdrawal of Meronem from July 31, 2017 to August 31, 2017, due to the delay in the divestment of ...

Meropenem (Meronem) is a carbapenem antibiotic, prescribed for bacterial infections like skin and skin structure infections, bacterial meningitis, serious nosocomial infections like septicaemia, ...

AstraZeneca Pharma India will stop selling anti-bacterial drug Meronem in India following a global deal by its parent AstraZeneca UK to sell its small molecule antibiotics business to Pfizer Inc. The ...